Long-Term Follow-up Protocol

Clinical trial NCT04917887 · RECRUITING

Trial details

NCT number: NCT04917887
Sponsor: Krystal Biotech, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Dystrophic Epidermolysis Bullosa Recessive Dystrophic Epidermolysis Bullosa Dominant Dystrophic Epidermolysis Bullosa

Start date: 2021-05-25
Primary completion: 2028-05-25
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.